Paul Industries delivers validation and commissioning in Maryland for cell therapy, biologics, vaccine and bioscience plants, taking new and modified systems from design review and commissioning through installation, operational and performance qualification to release, from Rockville, Gaithersburg and Germantown to Frederick, Urbana, Walkersville and Baltimore. Maryland is home to FDA’s headquarters and a concentrated cluster of biologics and cell therapy production, and new capacity is being built there now. Paul Industries commissions and qualifies process equipment, utilities and controlled environments, and builds many of those systems as well, so the records start at design instead of being reconstructed at the end.

Request a quote or call 201-450-8280

Headquarters 256 Shore Drive, Kilmarnock, Virginia
FDA headquarters White Oak campus, Silver Spring, Maryland
C&Q guide ISPE Baseline Guide Vol. 5, 2nd edition (2019)
Pressure equipment Maryland certificate of inspection required before use
Building energy rule BEPS for buildings of 35,000 sq ft or more; manufacturing exempt on application
Reviewed November 2026

Validation and commissioning in Maryland: plants, regulator and stakes

Validation and commissioning in Maryland centers on the I-270 corridor, Frederick County and Baltimore, where biologics, cell and gene therapy, vaccine and bioscience manufacturers make products for patients under FDA oversight. Commissioning proves a system was built and works as designed; qualification documents that it is fit for its GMP use; validation shows the process run on it makes acceptable product, consistently. Those steps sit between a mechanically complete building and the first released batch, and in Maryland they often run while the next phase of a site is still under construction.

The national approach, protocols and terminology are set out on the validation and commissioning page. This page covers what is particular to Maryland: the kinds of plants being built, what FDA’s inspection record in the state teaches, how Maryland’s boiler and building energy rules reach a qualification file, and how CQV in Maryland is planned around plants that keep producing.

Where does the Maryland biotech corridor build and make product?

The Maryland biotech corridor runs from Bethesda and Rockville up I-270 through Gaithersburg and Germantown to Frederick County, with a second cluster in and around Baltimore. The biotech industry in Maryland has moved steadily from research toward commercial manufacturing, and recent announcements show the scale. These are market facts about the state, named to describe what qualification work there involves.

Maryland manufacturing clusters and what qualification work centers on
AreaRecent market factsSystems most often qualified
RockvilleAstraZeneca opened a $300 million cell therapy manufacturing facility in May 2025; Samsung Biologics agreed in December 2025 to acquire GSK’s Rockville biologics site, with about 60,000 liters of drug substance capacityCell processing suites, cryogenic storage, large bioreactor trains, purification, water and clean steam
Gaithersburg and GermantownAstraZeneca plans a clinical manufacturing facility in Gaithersburg, at Novavax’s former headquarters, due to be fully running by 2029Multiproduct clinical suites, single-use equipment, phase-appropriate qualification
Frederick and UrbanaAstraZeneca’s $2 billion plan nearly doubles commercial capacity at its Frederick biologics plant by 2029; Kite’s Urbana CAR T plant received FDA approval for commercial production in 2022Commercial biologics expansion, autologous cell therapy, utilities on a running site
WalkersvilleLonza’s 116-acre Walkersville site is the headquarters and largest manufacturing site of Lonza Bioscience, making cell culture media and endotoxin testing productsMedia preparation and filling, environmental monitoring, temperature-controlled storage
BaltimoreVaccine, biologics and bioscience manufacturing alongside university and hospital researchContainment suites, vaccine processing, building utilities shared with labs

Commissioning qualification and validation on a Maryland project

Commissioning qualification and validation on a Maryland project follows the science- and risk-based model in ISPE’s Baseline Guide Volume 5, second edition (2019), which absorbed ASTM E2500, together with FDA’s 2011 process validation guidance and, for products shipped to Europe, EU GMP Annex 15. The model starts with what matters to the patient: user requirements name the critical quality attributes and process parameters, a system risk assessment identifies the critical aspects of each direct impact system, and testing concentrates on those aspects.

Commissioning carries most of the engineering testing: installation checks, loop checks, functional tests, factory and site acceptance tests and punch list closeout, done under good engineering practice and documented well enough that quality can rely on it. Qualification then verifies the critical aspects, using commissioning records where they are adequate instead of repeating the tests. Process validation, the stage FDA calls process performance qualification, runs the actual process on the qualified equipment, followed by continued process verification in routine production.

The practical benefit on a Maryland schedule is that testing is done once, by people who understand the equipment, with quality reviewing the plan and the results instead of every step. The risk is loosely written commissioning records that quality then rejects; Paul Industries writes commissioning test scripts with acceptance criteria, signatures and deviations handled the way a qualification protocol would handle them, so they carry into the qualification package intact.

How a Maryland CQV program runs from requirements to release
StageMain deliverablesApproval
Requirements and riskUser requirements, system classification, system risk assessments, validation master plan or C&Q planOwner quality unit and system owners
Design reviewDesign review or design qualification against requirements, traceability matrix startedEngineering and quality
Factory and site acceptanceFAT and SAT protocols and reports for skids and packaged equipmentEngineering, with quality review where records will be leveraged
CommissioningInstallation verification, loop checks, functional tests, punch list closeout, turnover packageEngineering under good engineering practice
QualificationIQ and OQ or integrated verification of critical aspects, deviations closed, summary reportOwner quality unit
Performance and processPQ for utilities and environments, process performance qualification batchesOwner quality unit, then routine monitoring

FDA’s home state: what Maryland plants take from it

FDA’s headquarters sits on the White Oak campus in Silver Spring, where the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research consolidated, CBER moving its offices and laboratories there from Rockville and Bethesda in 2014. Plants in Maryland are inspected to the same regulations as plants anywhere else, but the agency’s centers, many of its reviewers and a deep pool of former FDA staff sit within the region, and plants in the region draw on that experience when they prepare for inspection.

Inspection history makes the point. FDA inspection findings at vaccine plants in recent years have centered on the same few themes: cross-contamination that was not thoroughly investigated, cleaning and segregation gaps, and personnel and material flow that let one product reach another. Several of those findings trace back to facility design and qualification: pressure cascades and airlocks, segregation of products, cleanable surfaces and the movement of people and materials. Qualification of a multiproduct Maryland facility therefore tests those flows and differentials as carefully as it tests the equipment.

Qualifying cell therapy suites in Rockville, Gaithersburg and Urbana

Cell therapy suites in Rockville, Gaithersburg and Urbana bring qualification needs that differ from conventional biologics. Autologous products are made one patient at a time, so the suite runs many small, parallel batches where chain of identity and segregation matter as much as particle counts, and the equipment list is dominated by biosafety cabinets, incubators, closed processing systems, controlled-rate freezers, liquid nitrogen storage and cold chain shippers.

Each of those is qualified against how it is used. Biosafety cabinets are tested for airflow and filter integrity, incubators and freezers are temperature mapped empty and loaded, controlled-rate freezers are verified against their programmed profiles, and liquid nitrogen storage is qualified with alarms, level monitoring and oxygen depletion monitoring in the room. The cleanroom envelope around them, covered on the cleanrooms in Maryland page, is qualified for classification, recovery and pressure cascade. Electronic records from controllers and monitoring systems fall under 21 CFR Part 11 and are tested for audit trails, access control and data retention.

Large-scale biologics: bioreactor trains, water and clean steam

Large-scale biologics plants such as the expanding sites in Frederick and Rockville qualify stainless or hybrid bioreactor trains, harvest and purification skids, buffer and media preparation, and the utilities that serve them. Water for Injection and purified water systems follow a phased performance qualification with intensive sampling, clean steam is qualified for condensate quality and steam physical properties, and cleaning- and steam-in-place cycles are qualified for coverage, temperature and hold times before cleaning validation begins.

Paul Industries designs and builds many of these systems as well as qualifying them, as described on the high purity water systems in Maryland and CIP and SIP systems in Maryland pages. When the builder and the qualification team share one document system, weld maps, passivation reports, slope checks and instrument calibration records flow straight into the IQ, which shortens the time between mechanical completion and release.

How does Maryland’s boiler law reach an IQ for pressure equipment?

Pressure equipment in a Maryland qualification has a state record behind it, because the Boiler and Pressure Vessel Safety Act requires boilers and pressure vessels to be built to the ASME code, registered with the National Board and covered by a valid certificate of inspection before they operate. Installers notify the Chief Boiler Inspector at least 30 days before installation, and inspections follow on an annual or biennial cycle depending on the equipment. An IQ that verifies an autoclave, a bioreactor jacket, a clean steam generator or a WFI still therefore checks the state paperwork as well as the GMP documentation.

Maryland state records and GMP evidence for pressure equipment
EquipmentState and code recordWhat the IQ verifies
Steam sterilizer (autoclave)ASME nameplate and data report, National Board registration, Maryland certificate of inspectionNameplate matches the data report, relief valve settings, certificate current, utilities as designed
Stainless bioreactor or fermenterASME vessel data report for vessel and jacket, registration, certificateDesign pressures against process needs, relief devices, surface finish and passivation records
Clean steam generator and WFI stillPressure vessel records for shells and heat exchangers, certificateFeedwater quality, materials of construction, sanitary connections, instrument calibration
Plant boiler serving clean utilitiesBoiler registration and certificate, inspection reportsCapacity and pressure for the clean steam generator, treatment chemicals kept off product surfaces
Process tanks rated for pressure or vacuumVessel data report and registration where the law appliesRating, relief and vacuum protection, cleanability and drainability

New vessels for Maryland plants are covered on the pressure vessel fabrication in Maryland page. Keeping the state records in the qualification file means an FDA inspector, the boiler inspector and the owner’s insurer can each find what they need in one place.

Data integrity checks inside a Maryland qualification

Data integrity checks inside a Maryland qualification test whether the electronic records a system creates are reliable, which matters as much to an inspector as whether the equipment holds temperature. Bioreactor controllers, building management and environmental monitoring systems, autoclave and washer controllers, freezer monitoring and laboratory instruments all generate GMP records, and 21 CFR Part 11 and FDA’s data integrity guidance expect those records to be attributable, legible, contemporaneous, original and accurate.

Testing confirms that each user has a unique login with the right privileges, that audit trails capture who changed what and when and stay locked on for operators, that clocks are synchronized, that data is backed up and can be restored, and that alarms and electronic signatures work as specified. Interfaces between systems, such as a controller feeding a historian, are tested end to end so a value recorded on the floor matches the value in the report. Paul Industries writes these tests into the OQ alongside the functional checks, so the computerized side of a system is released together with the equipment it controls.

Lab buildings and BEPS: building commissioning beside GMP qualification

Maryland’s Building Energy Performance Standards, created under the Climate Solutions Now Act of 2022, apply to existing commercial, multifamily and state buildings of 35,000 square feet or more and require benchmarking and energy performance targets. Manufacturing buildings are among the exempt categories, though owners apply for the exemption, while laboratory and office buildings on the same campus are usually covered. Montgomery County, where much of the I-270 corridor sits, runs its own building energy program, and buildings there are waived from the state program because the county standards apply.

That rule brings two kinds of commissioning onto the same Maryland campus. Building commissioning and retro-commissioning, aimed at energy performance and owner requirements, apply to air handlers, chillers, boilers and controls in labs and offices. GMP commissioning and qualification apply to the systems that touch product or the controlled environment. The same air handler can serve both purposes, and when an energy upgrade changes airflow, setpoints or sequences on a GMP system, change control and requalification follow. The commissioning discipline Paul Industries applies to mission-critical facilities is described on the data center commissioning in Maryland page.

When do operating Maryland plants requalify a system?

Requalification at an operating Maryland plant is triggered by change and by time. Modifications to a qualified system, such as a new branch on a water loop, a replaced controller, a relocated room or a new product in a multiproduct suite, go through change control, an impact assessment and testing scaled to the risk the change introduces. Periodic review confirms that systems left unchanged remain in a state of control, with environmental monitoring trends, alarm histories and maintenance records reviewed against the original qualification.

Recurring work such as autoclave and cleanroom requalification, temperature mapping and periodic review is covered on the annual requalification page. IQ/OQ/PQ in Maryland plants that keep producing is scheduled into maintenance windows and campaign changeovers, with temporary controls in place when a system is out of service.

Why plan CQV at design on a Maryland site expansion?

CQV planning belongs at design on a Maryland site expansion because most new capacity in the state is being added beside qualified systems that are already making product. An expansion like the one announced for Frederick ties new bioreactors, purification trains and rooms into existing water loops, clean steam headers, HVAC systems, building automation and environmental monitoring, and every tie-in is a change to a qualified system with its own impact assessment, testing and approval.

Planning early sorts out which existing systems will be touched, which need requalification and in what order, which tie-ins can be made during a planned shutdown, and how the new equipment stays isolated from the qualified plant until its own testing is done. It also sets the document approach before any vendor starts building: the requirement numbering, the test script templates, the turnover index and the rules for using vendor and commissioning records. Settling those choices before procurement prevents the most expensive kind of rework in qualification, the kind where a finished system has to be retested because its records were built to the wrong template.

How much qualification does a clinical manufacturing suite need?

Clinical manufacturing suites, such as the Gaithersburg facility AstraZeneca has announced, are qualified to a level that protects the patients in the trial and the integrity of the data while recognizing that processes are still changing. Utilities, the controlled environment and equipment that touches product are qualified fully, because sterility, particulate control and temperature protect early-phase patients as much as commercial ones. Process validation in the commercial sense comes later, once the process is fixed.

Multiproduct clinical suites add their own needs: flexible equipment qualified over the full range it will run, single-use assemblies accepted on supplier documentation with incoming checks, cleaning and changeover verified for each product, and room status and line clearance procedures tested before the first batch. Paul Industries writes the qualification plan so the same records grow into commercial qualification when a product moves on, instead of being redone.

Which Maryland storage areas need temperature mapping?

Temperature mapping in Maryland plants covers every space where product, materials or samples are held under a labeled condition: cold rooms, freezers and ultra-low freezers, incubators, stability chambers, controlled room temperature warehouses and the docks where shipments wait. Maryland’s climate makes the warehouse studies seasonal, since humid summers and freezing winters push different parts of a building out of range, so controlled room temperature areas are usually mapped once in summer and once in winter before routine monitoring probes are placed at the worst-case points the studies find.

Each study defines the sensor grid, the duration, empty and loaded conditions, and door-opening and power-failure tests where the risk calls for them. Results set alarm limits and monitoring locations, and remapping follows changes to racking, HVAC or use. Paul Industries runs the studies, analyzes the data and writes the reports to the owner’s acceptance criteria.

How is a Maryland CQV program priced?

A Maryland CQV program is priced from the system list, the number of protocols, the extent to which commissioning records can be used in place of separate qualification tests, the review cycles the owner’s quality unit requires, and the schedule. A single autoclave requalification, a new purified water system and a full cell therapy facility differ by orders of magnitude, so Paul Industries prepares a budget range from comparable scope as soon as the system list is known and a firm price once requirements and the document approach are agreed.

The main cost drivers are the share of systems classified as direct impact, the number of protocol revisions, whether test equipment and calibration are included, temperature mapping and sampling volumes, computerized system testing, and the hours available for execution in an operating plant. Combining the build and the qualification under one contract removes the cost of reconstructing documents that were never collected during construction.

Who handles validation and commissioning in Maryland?

Paul Industries handles validation and commissioning in Maryland as one contractor for commissioning plans, test scripts, IQ, OQ and PQ protocols, execution, deviation handling, summary reports and turnover, for systems it builds and for equipment already on site. Paul Industries is headquartered at 256 Shore Drive, Kilmarnock, Virginia, was formerly based in northern New Jersey and then Pennsylvania, and takes CQV work across Maryland, in all 50 states and at plants outside the United States.

Owners can commission Paul Industries for the complete program, for a design-build package where the system and its qualification come together, or for the CQV execution of a single system. The headquarters-state version of this service is described on the validation and commissioning in Virginia page, and neighboring markets on the validation and commissioning in Pennsylvania and validation and commissioning in New York pages.

Commissioning and qualification from Paul Industries in Maryland

Paul Industries gives Maryland cell therapy, biologics, vaccine and bioscience plants a CQV program that starts with requirements and risk, uses commissioning evidence the quality unit can accept, and ends with an approved package ready for inspection. The work extends to the utilities and piping behind each system, described on the process piping in Maryland page, and every Maryland service is listed on the Maryland page. To scope qualification for a Maryland site, send the system list and schedule and request a quote.

Standards referenced: 21 CFR Parts 210 and 211 · 21 CFR Part 11 · 21 CFR Part 1271 · FDA Process Validation: General Principles and Practices (2011) · ISPE Baseline Guide Volume 5: Commissioning and Qualification, 2nd edition · ASTM E2500 · ICH Q9(R1) · EU GMP Annex 15 · EU GMP Annex 1 · ASME BPE · ISO 14644 · Maryland Boiler and Pressure Vessel Safety Act (COMAR 09.12.01) · Maryland Building Energy Performance Standards (COMAR 26.28)

Frequently asked questions

Who qualifies cell therapy and biologics suites in Rockville, Gaithersburg and Germantown?

Paul Industries commissions and qualifies cell therapy, biologics and clinical manufacturing suites in Rockville, Gaithersburg and Germantown, including biosafety cabinets, incubators, controlled-rate freezers, liquid nitrogen storage, cleanroom environments and the water, steam and gas utilities behind them. Protocols follow the owner’s quality system, and commissioning records are written so the quality unit can rely on them in qualification.

Does Paul Industries commission and qualify plants in Frederick, Urbana and Walkersville?

Yes. Paul Industries takes commissioning and qualification work at biologics, cell therapy and bioscience plants in Frederick, Urbana, Walkersville and across Frederick County, for new expansions and for changes on operating sites. Execution is planned around production schedules and campaign changeovers, and the turnover package ties every test to the requirement and risk assessment behind it.

Who provides CQV in Baltimore for vaccine, biologics and research facilities?

Paul Industries provides CQV in Baltimore for vaccine, biologics and bioscience manufacturers and for research facilities with GMP areas, from the harbor east to Halethorpe and the county campuses. Programs cover process equipment, clean utilities, controlled environments and containment features such as pressure cascades and airlocks, which inspections of multiproduct plants examine closely.

What is commissioning, qualification and validation, and who approves each stage?

Commissioning verifies that a system is installed and works as designed, under good engineering practice and approved by engineering. Qualification verifies the critical aspects that affect product quality and is approved by the owner’s quality unit. Validation, through process performance qualification, shows the process consistently makes acceptable product. The difference between commissioning, qualification and validation is mostly purpose and approval, since one well-written test can serve more than one stage.

Is Maryland a biotech hub for manufacturing as well as research?

Yes. Maryland’s corridor along I-270 began as a research center around NIH and the federal labs, and it now carries large manufacturing investments: AstraZeneca’s Rockville cell therapy plant and Frederick biologics expansion, Kite’s commercial CAR T plant in Urbana, Lonza’s bioscience operations in Walkersville and the Rockville biologics site Samsung Biologics agreed to acquire. FDA’s headquarters in Silver Spring sits in the same region.

Validation vs commissioning for a Maryland lab building under BEPS: which applies?

Both can apply in the same building. Building commissioning or retro-commissioning addresses energy performance and owner requirements for air handlers, chillers and controls, and Maryland’s BEPS or Montgomery County’s program pushes lab and office owners in that direction. GMP validation applies only to systems that affect product or a controlled environment. When an energy change touches a GMP system, change control and requalification follow.

How long does commissioning take for a new Maryland cell therapy suite?

The time depends on the equipment count, how much commissioning evidence the quality unit accepts and whether the cleanroom, utilities and equipment finish together. Commissioning of a suite’s environment and equipment generally runs several weeks to a few months, followed by environmental performance qualification and process simulations. Paul Industries shortens the path by starting test scripts during design and executing commissioning and qualification tests together where the plan allows.

Does being near FDA headquarters change how Maryland plants are inspected?

FDA applies the same regulations and inspection approach to Maryland plants as to plants in every other state. The practical difference is the people: the region holds FDA’s centers, many reviewers and a deep pool of former agency staff, so Maryland quality units tend to expect inspection-ready records from day one. Paul Industries prepares qualification packages to that expectation.

What lessons does the 2021 Bayview inspection hold for facility qualification?

FDA’s 2021 inspection of the Bayview vaccine plant in Baltimore cited an inadequately investigated cross-contamination, cleaning gaps and problems with how people and materials moved between areas. For qualification, the lessons are to test pressure cascades, airlock interlocks and room differentials under real door use, to verify gowning and material flows against the design, and to qualify cleaning for every product a multiproduct suite will handle.

How does Maryland's boiler law show up in an autoclave or vessel qualification?

Maryland requires boilers and pressure vessels to be built to the ASME code, registered with the National Board and covered by a valid certificate of inspection before operation, with installation notice given to the Chief Boiler Inspector at least 30 days ahead. An autoclave, bioreactor or clean steam generator IQ therefore checks the nameplate, data report, registration, relief settings and current certificate alongside the GMP documentation.

How are liquid nitrogen freezers and controlled-rate freezers qualified for cell therapy?

Liquid nitrogen storage is qualified for temperature at each storage level under normal use, alarm and level monitoring, hold time on supply loss and room oxygen monitoring. Controlled-rate freezers are verified against their programmed cooling profiles with independent probes, and their records are tested for Part 11 compliance. Shippers are qualified for hold time across expected transit conditions. Paul Industries maps and tests each unit against its user requirements.

How is a biosafety cabinet or isolator qualified in a Maryland suite?

Biosafety cabinets are tested for inflow and downflow velocity, HEPA filter integrity, airflow smoke patterns and alarms, and isolators for glove and chamber integrity, pressure hold, decontamination cycle effectiveness and environmental classification. Placement in the room matters, since supply diffusers and door traffic disturb the air curtain. Paul Industries qualifies each unit in its final location and repeats the tests after relocation or filter change.

What changes in qualification when a Maryland biologics site moves to contract manufacturing?

A site that starts making products for several clients needs equipment and utilities qualified for a wider operating range, cleaning validated for each new product and its worst-case residues, and change control that handles frequent product introductions. Segregation, line clearance and campaign changeover procedures receive more testing. Paul Industries reviews the existing qualification against the new product mix and closes the gaps before the first client batch.

When does a change to a qualified Maryland system need requalification?

Any change that could affect a critical aspect needs an impact assessment under change control, and the testing that follows matches the risk: a like-for-like part swap may need only verification, while a new loop branch, a replaced controller or a changed sequence of operation needs targeted IQ and OQ and sometimes PQ. Periodic review also triggers requalification when trends drift.

What drives the cost of qualifying a cell therapy suite?

The main drivers are the number of equipment items and rooms, the share classified as direct impact, temperature mapping and environmental monitoring volumes, the computerized systems to be tested, protocol review cycles and the hours available for execution. Paul Industries offers a budget range from comparable suites once the equipment list is known, then a firm price once requirements and the document approach are agreed.

How is CQV executed at a Maryland plant without stopping production?

Execution is broken into packages that fit maintenance windows, weekends and campaign changeovers, with temporary controls and backup equipment in place while a system is out of service. New systems are isolated from qualified ones until testing ends, and tie-ins are planned with the plant’s change control. Paul Industries schedules each test with production planning so release dates hold.

Which documents make up the final CQV package for a Maryland plant?

The final package holds the user requirements, risk assessments, the C&Q or validation plan, design review records, FAT and SAT reports, commissioning records, executed IQ, OQ and PQ protocols with deviations closed, a traceability matrix, calibration certificates for test instruments, state pressure equipment records where applicable, and summary reports approved by the quality unit, in the owner’s document format.

Which project details let Paul Industries scope CQV for a Maryland site?

Send the system and equipment list, user requirements if written, P&IDs and layouts, the owner’s validation master plan or SOP set, the product type and regulatory markets, schedule milestones and the state of construction or operation. For existing systems, include current qualification reports and change history. Paul Industries uses that information to propose the approach, protocol list and budget.

Qualifying new systems at a Maryland plant?

Send the system list, user requirements, drawings and your target release date. Call 201-450-8280 or request a quote.